Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Multicentre, Randomized, Open, Parallel Group Study on the Efficacy and Safety of Bemiparin Sodium (LMWH) Compared to Enoxaparin Sodium (LMWH) in the Treatment of Acute Deep Vein Thrombosis (DVT)

NCT01880216 is registered in ClinicalTrials.gov with Berlin-Chemie AG Menarini Group as lead sponsor.

NCT NCT01880216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01880216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Multicentre, Randomized, Open, Parallel Group Study on the Efficacy and Safety of Bemiparin Sodium (LMWH) Compared to Enoxaparin Sodium (LMWH) in the Treatment of Acute Deep Vein Thrombosis (DVT)
Lead sponsor
Berlin-Chemie AG Menarini Group
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2013
Completion date
May 31, 2015
Enrollment
312 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis